EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial

Eleonora Cristarella, Margherita Ambrosini, Massimo Di Maio, Sara Lonardi, Ferdinando De Vita, Samantha Di Donato, Elisa Giommoni, Andrea Spallanzani, Alessandro Bittoni, Claudio Chini, Antonia Strippoli, Tiziana Pia Latiano und 8 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116060 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Eleonora Cristarella und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Paclitaxel, Antineoplastic Combined Chemotherapy Protocols, Stomach Neoplasms, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelAntineoplastic Combined Chemotherapy ProtocolsStomach NeoplasmsEsophageal NeoplasmsPatient Reported Outcome MeasuresEsophagogastric JunctionHumansRamucirumabFemaleAntibodies, Monoclonal, HumanizedMaleMiddle AgedQuality of LifeAgedAdultFluorouracilLeucovorinMaintenance ChemotherapyProgression-Free Survival

Stichwörter der Autor:innen

Gastroesophageal cancerPaclitaxel plus ramucirumabQuality of lifeRandomized clinical trialSwitch maintenance

Substanzen

RamucirumabPaclitaxelAntibodies, Monoclonal, HumanizedFluorouracilLeucovorin

Autor:innen und Institutionen

  • Department of Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Department of Oncology, Veneto Institute of Oncology Istituto Oncologico Veneto - IRCCS, Padua, Italy.
  • Division of Medical Oncology, Department of Precision Medicine, University of Campania "L Vanvitelli", Naples, Italy.
  • Medical Oncology Department ASL Toscana Centro, Santo Stefano Hospital, Prato, Italy.
  • Oncology Unit, Careggi University Hospital, Florence, Italy.

Zitieren

APA

Cristarella, E., Ambrosini, M., Di Maio, M., Lonardi, S., De Vita, F., Di Donato, S., Giommoni, E., Spallanzani, A., Bittoni, A., Chini, C., Strippoli, A., Latiano, T. P., Brunetti, O., Tamberi, S., Cardellino, G. G., Spada, D., Fornaro, L., Alessandrini, S., Pietrantonio, F., & Randon, G. (2025). Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116060

Vancouver

Cristarella E, Ambrosini M, Di Maio M, Lonardi S, De Vita F, Di Donato S, et al. Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116060

BibTeX
@article{Cristarella2025,
  author = {Cristarella, Eleonora and Ambrosini, Margherita and Di Maio, Massimo and Lonardi, Sara and De Vita, Ferdinando and Di Donato, Samantha and Giommoni, Elisa and Spallanzani, Andrea and Bittoni, Alessandro and Chini, Claudio and Strippoli, Antonia and Latiano, Tiziana Pia and Brunetti, Oronzo and Tamberi, Stefano and Cardellino, Giovanni Gerardo and Spada, Daniele and Fornaro, Lorenzo and Alessandrini, Sara and Pietrantonio, Filippo and Randon, Giovanni},
  title = {Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116060}
}
Kostenlos starten →